Beam Therapeutics logo

Beam Therapeutics

A synthetic biology company using CRISPR to develop a portfolio of genetic medicines.

5

Funding Rounds

$689.0m

Money raised

Overview

A synthetic biology company using CRISPR to develop a portfolio of genetic medicines.

Unlock Complete Company Intelligence

Access comprehensive data and insights available only to Seedtable members

Financial Details

  • • Complete funding history and valuations
  • • Revenue estimates and financial metrics
  • • Investment round details and terms

People & Contacts

  • • Complete leadership team profiles
  • • Contact information and email addresses
  • • Board members and advisors

Market Intelligence

  • • Competitive landscape analysis
  • • Market position and growth metrics
  • • Industry benchmarking data

Premium Tools

  • • Export data and generate reports
  • • Save companies to custom watchlists
  • • API access for data integration

Join 10,000+ Professionals

Trusted by investors, founders, and analysts worldwide

Access detailed insights on 71,000+ companies worldwide

Funding

Funding series

Funding Series Analysis

The company Beam Therapeutics has raised a total of $554m in funding over 5 rounds.

Key Insights:

  • Beam Therapeutics Venture round, January 19, 2021: $260m
  • Beam Therapeutics Venture round, February 11, 2020: $207m
  • Beam Therapeutics Series A round, May 2018: $87m
  • Beam Therapeutics Inc. funding round, March 2019: $135m